MS/MS Data Project
This laboratory quality improvement initiative strives to improve the analytical quality of newborn screening by tandem mass spectrometry (MS/MS) by:
- achieving universal tandem mass spectrometry (MS/MS) testing of newborns for a uniform panel of metabolism and congenital adrenal hyperplasia (CAH);
- improving overall analytical performance;
- setting and sustaining the lowest achievable rates of false-positive results; and
- improving and standardizing confirmatory testing and short-term follow up.
Started as a Region 4 project in 2004, this project continues to expand and currently includes states from all seven genetics regions as well as international participants from other countries.
